11/5
12:37 pm
kymr
Rating for KYMR
Low
Report
Rating for KYMR
11/5
12:37 pm
kymr
Rating for KYMR
Low
Report
Rating for KYMR
11/5
09:57 am
kymr
Rating for KYMR
Low
Report
Rating for KYMR
11/5
09:57 am
kymr
Rating for KYMR
Low
Report
Rating for KYMR
11/5
07:19 am
kymr
Kymera Therapeutics (NASDAQ:KYMR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Kymera Therapeutics (NASDAQ:KYMR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
11/5
07:19 am
kymr
Kymera Therapeutics (NASDAQ:KYMR) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Kymera Therapeutics (NASDAQ:KYMR) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/4
04:07 pm
kymr
Kymera Therapeutics (NASDAQ:KYMR) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Low
Report
Kymera Therapeutics (NASDAQ:KYMR) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
11/4
04:07 pm
kymr
Kymera Therapeutics (NASDAQ:KYMR) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Kymera Therapeutics (NASDAQ:KYMR) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
11/4
04:07 pm
kymr
Kymera Therapeutics (NASDAQ:KYMR) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Kymera Therapeutics (NASDAQ:KYMR) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
11/4
05:49 am
kymr
Kymera Therapeutics (NASDAQ:KYMR) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Medium
Report
Kymera Therapeutics (NASDAQ:KYMR) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
11/4
05:49 am
kymr
Kymera Therapeutics (NASDAQ:KYMR) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Medium
Report
Kymera Therapeutics (NASDAQ:KYMR) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
11/3
08:12 am
kymr
Rating for KYMR
Medium
Report
Rating for KYMR
11/3
08:12 am
kymr
Rating for KYMR
Medium
Report
Rating for KYMR
10/23
06:16 am
kymr
Kymera Therapeutics (NASDAQ:KYMR) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Medium
Report
Kymera Therapeutics (NASDAQ:KYMR) was upgraded by analysts at Mizuho to a "strong-buy" rating.
10/23
06:16 am
kymr
Kymera Therapeutics (NASDAQ:KYMR) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Medium
Report
Kymera Therapeutics (NASDAQ:KYMR) was upgraded by analysts at Mizuho to a "strong-buy" rating.
10/22
07:32 am
kymr
Rating for KYMR
Low
Report
Rating for KYMR
10/21
08:36 am
kymr
Rating for KYMR
Medium
Report
Rating for KYMR
10/21
08:36 am
kymr
Rating for KYMR
Medium
Report
Rating for KYMR
10/21
08:03 am
kymr
Kymera Therapeutics (NASDAQ:KYMR) is now covered by analysts at Mizuho. They set an "outperform" rating and a $81.00 price target on the stock.
Medium
Report
Kymera Therapeutics (NASDAQ:KYMR) is now covered by analysts at Mizuho. They set an "outperform" rating and a $81.00 price target on the stock.
10/21
08:03 am
kymr
Kymera Therapeutics (NASDAQ:KYMR) is now covered by analysts at Mizuho. They set an "outperform" rating and a $81.00 price target on the stock.
Medium
Report
Kymera Therapeutics (NASDAQ:KYMR) is now covered by analysts at Mizuho. They set an "outperform" rating and a $81.00 price target on the stock.
10/20
04:13 pm
kymr
Kymera Therapeutics initiated with an Outperform at Mizuho
Medium
Report
Kymera Therapeutics initiated with an Outperform at Mizuho
10/20
04:13 pm
kymr
Kymera Therapeutics initiated with an Outperform at Mizuho
Medium
Report
Kymera Therapeutics initiated with an Outperform at Mizuho
10/17
11:24 am
kymr
Rating for KYMR
Medium
Report
Rating for KYMR
10/17
11:24 am
kymr
Rating for KYMR
Medium
Report
Rating for KYMR
10/17
07:20 am
kymr
Kymera Therapeutics (NASDAQ:KYMR) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Kymera Therapeutics (NASDAQ:KYMR) had its "buy" rating reaffirmed by analysts at Citigroup Inc..